501 related articles for article (PubMed ID: 12598410)
61. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
62. Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.
Keita AV; Carlsson AH; Cigéhn M; Ericson AC; McKay DM; Söderholm JD
Neurogastroenterol Motil; 2013 Jun; 25(6):e406-17. PubMed ID: 23600853
[TBL] [Abstract][Full Text] [Related]
63. Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma.
Magro F; Fraga S; Soares-da-Silva P
Br J Pharmacol; 2005 May; 145(1):93-103. PubMed ID: 15723092
[TBL] [Abstract][Full Text] [Related]
64. Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine.
Banks MR; Farthing MJ; Robberecht P; Burleigh DE
Br J Pharmacol; 2005 Apr; 144(7):994-1001. PubMed ID: 15711593
[TBL] [Abstract][Full Text] [Related]
65. Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes.
Qian BF; Hammarström ML; Danielsson A
J Neuroendocrinol; 2001 Sep; 13(9):818-25. PubMed ID: 11578532
[TBL] [Abstract][Full Text] [Related]
66. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.
Frølund S; Holm R; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Oct; 161(3):589-600. PubMed ID: 20880398
[TBL] [Abstract][Full Text] [Related]
67. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
Sun D; Landowski CP; Chu X; Wallsten R; Komorowski TE; Fleisher D; Amidon GL
AAPS PharmSci; 2001; 3(1):E2. PubMed ID: 11741253
[TBL] [Abstract][Full Text] [Related]
68. Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells.
D'Souza VM; Buckley DJ; Buckley AR; Pauletti GM
J Pharm Sci; 2003 Mar; 92(3):594-603. PubMed ID: 12587121
[TBL] [Abstract][Full Text] [Related]
69. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
70. Direct assessment of dipeptide/H+ symport in intact human intestinal (Caco-2) epithelium: a novel method utilising continuous intracellular pH measurement.
Thwaites DT; Hirst BH; Simmons NL
Biochem Biophys Res Commun; 1993 Jul; 194(1):432-8. PubMed ID: 8333858
[TBL] [Abstract][Full Text] [Related]
71. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells.
Collado B; Gutiérrez-Cañas I; Rodríguez-Henche N; Prieto JC; Carmena MJ
Regul Pept; 2004 Jun; 119(1-2):69-75. PubMed ID: 15093699
[TBL] [Abstract][Full Text] [Related]
72. Activation of the Na+-K+(NH4+)-2Cl(-)- cotransporter from rat submandibular glands in response to VIP.
Chaïb N; Kabré E; Métioui M; Alzola E; Amsallem H; Marino A; Moran A; Dehaye JP
Peptides; 1998; 19(10):1759-70. PubMed ID: 9880083
[TBL] [Abstract][Full Text] [Related]
73. Interferon-gamma increases hPepT1-mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia.
Buyse M; Charrier L; Sitaraman S; Gewirtz A; Merlin D
Am J Pathol; 2003 Nov; 163(5):1969-77. PubMed ID: 14578196
[TBL] [Abstract][Full Text] [Related]
74. Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.
Matsumoto S; Saito H; Inui K
J Pharmacol Exp Ther; 1994 Aug; 270(2):498-504. PubMed ID: 8071843
[TBL] [Abstract][Full Text] [Related]
75. Creation of a selective antagonist and agonist of the rat VPAC(1) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template.
Tams JW; Jorgensen RM; Holm A; Fahrenkrug J
Mol Pharmacol; 2000 Nov; 58(5):1035-41. PubMed ID: 11040051
[TBL] [Abstract][Full Text] [Related]
76. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
Terada T; Sawada K; Saito H; Hashimoto Y; Inui K
Am J Physiol; 1999 Jun; 276(6):G1435-41. PubMed ID: 10362647
[TBL] [Abstract][Full Text] [Related]
77. H(+)-coupled alpha-methylaminoisobutyric acid transport in human intestinal Caco-2 cells.
Thwaites DT; McEwan GT; Hirst BH; Simmons NL
Biochim Biophys Acta; 1995 Mar; 1234(1):111-8. PubMed ID: 7880851
[TBL] [Abstract][Full Text] [Related]
78. Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
Kikuchi A; Tomoyasu T; Tanaka M; Kanamitsu K; Sasabe H; Maeda T; Odomi M; Tamai I
J Pharm Sci; 2009 May; 98(5):1775-87. PubMed ID: 18781650
[TBL] [Abstract][Full Text] [Related]
79. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Omkvist DH; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
[TBL] [Abstract][Full Text] [Related]
80. (N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines.
Zia H; Leyton J; Casibang M; Hau V; Brenneman D; Fridkin M; Gozes I; Moody TW
Life Sci; 2000; 66(5):379-87. PubMed ID: 10670826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
